HanchorBio Inc. (TPE:7827)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
154.50
-4.50 (-2.83%)
At close: Jul 20, 2026
Market Cap20.12B +178.0%
Revenue (ttm)312.22M
Net Income-512.93M
EPS-4.10
Shares Out 130.21M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume282,591
Open161.00
Previous Close159.00
Day's Range152.00 - 161.00
52-Week Range59.60 - 187.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About HanchorBio

HanchorBio Inc. operates as a biotechnology company that develops biologics for cancer patients. The company offers FBDB platform to develop biological medicines. The company also engages in novel target research and evaluation, development of in vitro and in vivo models for evaluating the bioactivities of anti-cancer drugs, and development of proteins. HanchorBio Inc. was founded in 2020 and is based in Taipei, Taiwan with an additional office in Shanghai, China. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Employees 127
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7827
Full Company Profile

Financial Performance

Financial Statements